谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 216 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
APOBEC in Breast Cancer: a Dual Player in Tumor Evolution and Therapeutic Response
Haiqi Lu, Zelin Lu, Yufei Wang, Miaoqin Chen,Guangliang Li,Xian Wang
Frontiers in molecular biosciences (2025): 1604313-1604313
引用0浏览0WOS引用
0
0
Results of a Phase 1/2 Study of Sacituzumab Tirumotecan in Patients with Unresectable Locally Advanced or Metastatic Solid Tumors Refractory to Standard Therapies
Quchang Ouyang,Jordi Rodon, Yan Liang,Xinhong Wu,Qun Li,Lihua Song,Min Yan,Zhongsheng Tong,YunPeng Liu, Zev A. Wainberg, Ying Wang,Cuizhi Geng, Susanna V. Ulahannan,Guohua Yu, Manish R. Sharma,Xiang Wang,Judy S. Wang,Alexander Spira, Weihong Zhao, Rachel E. Sanborn,Ying Cheng,Xian Wang, Gesha Liu, Yaling Li,Junyou Ge, Elliot Chartash, Omobolaji O. Akala,Yongmei Yin
Journal of Hematology & Oncologyno. 1 (2025): 1-13
引用0浏览0WOS引用
0
0
Capivasertib Plus Fulvestrant in Patients with HR-positive/HER2-negative Advanced Breast Cancer: Phase 3 CAPItello-291 Study Extended Chinese Cohort
Xichun Hu,Qingyuan Zhang,Tao Sun,Huihua Xiong,Wei Li,Yuee Teng,Yen-Shen Lu,Ling-Ming Tseng,Min Yan,Hongsheng Li,Danmei Pang, Shin-Cheh -Chen, Wenyan Chen, Ou Jiang, Jingfen Wang,Xinhong Wu,Xian Wang,Aimin Zang,Xiaojia Wang, Julie M Collins, Ethan Fan, Lin Jiang, Xiaoling Zeng, Nicholas C Turner
Nature communicationsno. 1 (2025): 4324-4324
引用0浏览0WOSNATURE引用
0
0
LZTS2 Methylation As a Potential Diagnostic and Prognostic Marker in LIHC and STAD: Evidence from Bioinformatics and in Vitro Analyses
Xiao Wang,Yanwei Lu,Ruiqi Liu, Luanluan Huang, Keke Xu, Hao Xiong, Ding Nan, Yiyi Shou, Hailong Sheng,Haibo Zhang,Xian Wang, Xiaoyan Chen
Scientific reportsno. 1 (2025): 17873-17873
引用0浏览0WOS引用
0
0
加载更多
作者统计

#Papers: 217

#Citation: 8326

H-Index: 48

G-Index: 88

Sociability: 7

Diversity: 4

Activity: 55

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn